首页 社会内容详情
U8hash官网:Sanofi ends cancer drug trials

U8hash官网:Sanofi ends cancer drug trials

分类:社会

网址:

SEO查询: 爱站网 站长工具

点击直达

澳5开户www.a55555.net)是澳洲幸运5彩票官方网站,开放澳洲幸运5彩票会员开户、澳洲幸运5彩票代理开户、澳洲幸运5彩票线上投注、澳洲幸运5实时开奖等服务的平台。

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

PARIS: Sanofi is ending development of a key cancer medicine in a blow to the French drugmaker’s pipeline of experimental therapies.

The decision to stop all studies with amcenestrant follows an analysis of late-stage trial data evaluating the drug in patients with a type of breast cancer, the company said in a statement yesterday.

The move leaves Sanofi even more dependent for growth on blockbuster Dupixent, an antibody treatment for ailments ranging from asthma to severe eczema.

The company’s slate of experimental medicines has faced other setbacks, including safety concerns regarding multiple sclerosis treatment tolebrutinib.

,

U8hash官网www.eth108.vip)采用以太坊区块链高度哈希值作为统计数据,U8hash官网单双哈希、幸运哈希、平倍牛牛等游戏数据开源、公平、无任何作弊可能性。

,

Sanofi has included both amcenestrant and tolebrutinib as among six products in its pipeline that it prioritised as “potentially transformative” treatments.

Some investors are questioning the company’s growth trajectory after both of those medicines encountered problems.

UBS analysts last week downgraded Sanofi, saying there are few major catalysts coming soon to drive more excitement to the stock. — Bloomberg


转载说明:本文转载自Sunbet。
  • 线上博彩平台排名(www.99cx.vip) @回复Ta

    2022-09-07 00:27:21 

    中新社华盛顿2月3日电 针对美国媒体涉北京冬奥会言论,中国驻美大使馆发言人刘鹏宇日前致函《华盛顿邮报》表示,奥运会是体育盛会,不是政治舞台。北京冬奥会是弘扬奥林匹克精神的竞技场,不应受到政治干扰和操纵。以前怎么没看到这个

发布评论